Neuraceq™ PET for Detection of Brain Changes in Young Athletes Post-concussion

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

July 13, 2017

Primary Completion Date

October 10, 2019

Study Completion Date

October 10, 2019

Conditions
Concussion, Brain
Interventions
DIAGNOSTIC_TEST

NeuraCeq PET imaging with intravenous (IV) dose of 300MBq of Neuraceq™ ([F-18]Florbetaben)

Participants will receive an intravenous (IV) dose of 300 MBq of Neuraceq™ in a volume of 10 mL or less. A 30 minute duration PET image will be acquired starting immediately after Neuraceq™ injection. A second 20-minute duration PET image will be acquired starting 90 minutes after Neuraceq™ injection.

Trial Locations (1)

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT05270083 - Neuraceq™ PET for Detection of Brain Changes in Young Athletes Post-concussion | Biotech Hunter | Biotech Hunter